Akeso’s Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for the first-line treatment of recurrent or metastatic nasopharyngeal cancer (NPC) in combination with chemotherapy. Previously, penpulimab was approved for use as a third-line treatment for advanced NPC. With this new approval, […]

The Henderson Becomes First Commercial Building in APAC to Partner with Forbes Travel Guide on Five-Star Guest Experience Standards

The Henderson, a new iconic landmark for Hong Kong and a super Grade-A commercial development developed by Henderson Land Group, has become the first commercial building in the Asia-Pacific region to receive “In Partnership with Forbes Travel Guide” recognition for its commitment to elevating the guest experience to hospitality standards. More than just a commercial

The Henderson Becomes First Commercial Building in APAC to Partner with Forbes Travel Guide on Five-Star Guest Experience Standards

The Henderson, a new iconic landmark for Hong Kong and a super Grade-A commercial development developed by Henderson Land Group, has become the first commercial building in the Asia-Pacific region to receive “In Partnership with Forbes Travel Guide” recognition for its commitment to elevating the guest experience to hospitality standards. More than just a commercial

NEW ONE MICHELIN STAR ENTRY: PLAISANCE BY MAURO COLAGRECO AWARDED FIRST MICHELIN STAR IN MICHELIN GUIDE HONG KONG & MACAU 2025

Plaisance by Mauro Colagreco is proud to announce that it has been awarded its first Michelin star in the MICHELIN Guide Hong Kong & Macau 2025. https://mma.prnewswire.com/media/2641871/Chef_Mauro_Colagreco___Chef_Mitsuru_Konishi.jpg https://mma.prnewswire.com/media/2641872/Plaisance_by_Mauro_Colagreco_team_photo.jpg Since its opening in December 2023, Plaisance by Mauro Colagreco has captured attention with its unique ocean concept. The restaurant's mastermind, Chef Mauro Colagreco, seamlessly blends marine

AZIMUT|BENETTI GROUP LEADS THE NAUTICAL WORLD FOR A QUARTER CENTURY

Azimut|Benetti Group is the world's leading manufacturer of mega yachts for the twenty-fifth year, with a share of 20% of the global market. Azimut|Benetti Group is number one in the production of mega yachts over 24 meters, leading the industry in the Global Order Book 2025, the annual ranking by the reference publication Boat International

Jones Day adds Corporate partner Frank Voon in Hong Kong

The global law firm Jones Day today announced that Frank Voon has joined the Firm as a partner in its Corporate Practice. He is based in Jones Day's Hong Kong Office. https://mma.prnewswire.com/media/2642504/Jones_Day_Frank_Voon.jpg Mr. Voon has more than 20 years of experience advising on complex, cross-border M&A and private equity transactions across multiple industries, including automotive,

CITIC Resources Announces 2024 Annual Results, Revenue surges 148.3% to approximately HK$9.5 billion

CITIC Resources Holdings Limited (hereinafter referred to as the CITIC Resources or the Company, or the Group when its subsidiaries are included; Stock Code: 1205.HK) has announced its annual results for the year ended 31 December 2024 (hereinafter referred to as the 'Year'). Stable operating results with positive outlook. Breakthrough in revenue and profit growth.

Mitsubishi Electric Building Solutions Launches New Control Renewal Menu for Elevators Manufactured by Other Companies Overseas

Mitsubishi Electric Building Solutions Corporation (MEBS, Head Office: Chiyoda-Ku, Tokyo; President: Iwao Oda) today announced the launch scheduled for 19 March of a new overseas control renewal menu for elevators made by other companies installed in existing buildings. By developing a new control panel with an auto-tuning function, MEBS will respond to the diverse needs

Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial’s Design – Hagens Berman

(NYSE:NVO), SAN FRANCISCO, March 16, 2025 (GLOBE NEWSWIRE) — Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSema. Hagens Berman urges investors who purchased Novo Nordisk shares and suffered substantial losses to submit your losses now.

XYZ DEADLINE ALERT: Block, Inc. (XYZ) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 18th Deadline in Securities Class Action

(NYSE:SQ),(NYSE:XYZ), SAN FRANCISCO, March 16, 2025 (GLOBE NEWSWIRE) — Investors in Block, Inc. (NYSE: SQ) n/k/a (NYSE: XYZ) began to learn of potentially adverse information about the company and its Square and Cash App platforms on Mar. 23, 2023, when Hindenburg Research published a scathing report on the company. After a 2-year investigation, which included

Scroll to Top